TW201204834A - Combination for tooth regeneration - Google Patents

Combination for tooth regeneration Download PDF

Info

Publication number
TW201204834A
TW201204834A TW99123850A TW99123850A TW201204834A TW 201204834 A TW201204834 A TW 201204834A TW 99123850 A TW99123850 A TW 99123850A TW 99123850 A TW99123850 A TW 99123850A TW 201204834 A TW201204834 A TW 201204834A
Authority
TW
Taiwan
Prior art keywords
combination
growth hormone
stem cells
polymer
protein
Prior art date
Application number
TW99123850A
Other languages
Chinese (zh)
Inventor
Man-Jung Hung
Original Assignee
Kuo Shan Huei
Man-Jung Hung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuo Shan Huei, Man-Jung Hung filed Critical Kuo Shan Huei
Priority to TW99123850A priority Critical patent/TW201204834A/en
Publication of TW201204834A publication Critical patent/TW201204834A/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

A combination for tooth regeneration used in combination with adipose stem cells is provided, and the combination comprises a growth factor and an artificial and/or natural polymer. Tooth regeneration can be carried out by implanting the combination along with adipose stem cells into a tooth socket.

Description

201204834 六、發明說明: 【發明所屬之技術領域】 本發明係關於—種用於再生牙齒之組合,尤其關於-種與脂肪 幹細胞併用以再生牙齒之組合。 曰 【先前技術】 於牙科治療中,當牙齒因虹牙、年齡增長、齒列橋正手術等因 素而有缺㈣經拔除時’―般會以補牙、植牙或假牙重建等方式 φ進行治療。不論是補牙、植牙或假牙重建,目前皆是使用人工材 質來取代原本的牙齒成分,例如鈦金屬、£'或複合樹脂等。然 而’人體對於人工材質可能產生排斥性,且人卫材質易因不耐磨 損而須要重覆修補,甚至失去整顆牙齒。因此,若可使牙齒自然 地再生’則可避免因使用人工材質治療或重建牙齒而產生的各 問題。 再生醫學之技術包含使幹細胞分化為特定的細胞種類並結合 _ 組織工程,使其生長為新的組織或器官以取代損壞的組織或器 官,從而發揮正常的生理功能。就牙齒再生醫學而言,目前業已 使用牙髓幹細胞、牙周韌帶幹細胞及骨髓間質幹細胞作為幹細胞 之來源以進行研究,其令,儘管牙髓幹細胞及牙周韌帶幹細胞可 作為牙齒再生之最直接的細胞來源,惟因其於人體内的存在量稀 少,故難以取得足夠的量而進行治療;而骨髓間質幹細胞除具有 可獲得量稀少的缺點外,又易因年齡增長而老化,且須以抽取骨 髓之方式獲得,故於實際應用上多有侷限。另一方面,除了幹細 胞來源外,如何選用合適的生長激素和細胞支架(scaffold)成分, 3 201204834 以使幹細胞分化、並進一步生長為結構健全且功能完整的牙齒, 亦為牙齒再生醫學之關鍵所在。因此,為了使再生醫學可實際應 用於臨床之牙科治療上,須要一種穩定、豐富且易於取得之幹細 胞來源。 本發明即係針對上述需求所為之研究,本案發明人發現使用脂 肪幹細胞(adipose stem cell)與生長激素及生醫材料的組合,可 成功使牙齒再生,且再生之牙齒具有健全的結構與功能。 【發明内容】 本發明之一目的在於提供一種與脂肪幹細胞併用以再生牙齒之 組合,其包含一生長激素及一人工及/或天然之聚合物。 本發明之另一目的在於提供一種用於再生牙齒之組合,其包含 脂肪幹細胞、一生長激素及一人工及/或天然之聚合物。 本發明之詳細技術及較佳實施態樣,將描述於以下内容中,以 供本發明所屬領域具通常知識者據以明瞭本發明之特徵。 【實施方式】 如上述,目前補牙、植牙或假牙重建皆是使用人工材質作為自 然牙齒成分的替代品,惟其具有產生排斥性或因磨損而須重覆修 補的缺點,而牙齒再生醫學可解決此問題。然而,目前研究的牙 髓幹細胞、牙周韌帶幹細胞或骨髓間質幹細胞並無法作為穩定且 豐富的幹細胞來源。 脂肪幹細胞屬於成體幹細胞(adult stem cell),具有不易老化之 特性,且可利用一般抽脂手術而大量取得,故可作為穩定且豐富 201204834 的幹細胞來源。此外,脂肪幹細胞的免疫排斥性低,故可進行同 種動物間之脂肪幹細胞的異體移植,而不限於自體移植,因此, 其具有高度的運用彈性。有鑒於此,本發明將脂肪幹細胞運用於 牙齒再生醫學,而提供一種與脂肪幹細胞併用以再生牙齒之組 合,且該組合包含一生長激素及一人工及/或天然之聚合物。 於本發明之組合中,可使用選自以下群組之生長激素:成骨蛋 白(bone morphogenetic protein,BMP)、齒質基質蛋白(dentin matrix protein,DMP )、生長分化因子(Growth/differentiation factor,Gdf)、及前述之組合。該生長激素係作為一種訊息分子, 促使脂肪幹細胞進行分化,並進而形成牙齒組織。 成骨蛋白亦稱為骨形態發生蛋白,目前已知有二十種不同的成 骨蛋白,其係一種轉化生長因子(transforming growth factor )’可 誘導未分化之間質幹細胞(mesenchymal stem cell )分化成軟骨細 胞或成骨細胞並促使其增生,故成骨蛋白參與軟骨及成骨的生長 發育及修復重建過程。成骨蛋白除可促進軟骨和成骨之形成,亦 可調節組織或器官之胚胎細胞的發育與形態發生。齒質基質蛋白 或稱為牙本質基質蛋白,係一種參與骨骼及牙齒鈣化過程之非膠 原性蛋白質,其由骨細胞或齒質母細胞分泌至細胞外,以促進骨 生成或齒質形成。生長分化因子則係細胞發育的重要生物訊息分 子,可促進軟骨細胞增生及牙周組織形成。 較佳地,本發明組合可包含選自以下群組之生長激素:成骨蛋 白-2 ( BMP-2 )、成骨蛋白-4 ( BMP-4 )、成骨蛋白-7 ( BMP-7 )、成 骨蛋白-11 (BMP-11)、齒質基質蛋白-1 (DMP-1)、生長分化因子 -11 ( Gdf-11 )、及前述之組合。最佳地,該組合係包含成骨蛋白-2。 201204834 成骨蛋白-2是一種分子量為約30千道爾頓(kDal)之雙硫鍵同型 二聚體蛋白質,其可自動物體内純化而取得,或利用人工基因選 殖的方式製得。然而,由於成骨蛋白-2於動物體内的含量甚少, 且不同個體來源之成骨蛋白-2對於誘導幹細胞分化的活性差異度 甚大,故通常係使用人工基因選殖之成骨蛋白-2。於本發明之一 實施態樣中,係使用基因重組之人類成骨蛋白-2 ( recombinant human BMP-2 )。 於本發明之組合中,係包含一聚合物,以作為脂肪幹細胞分化、 並進而形成牙齒組織時的支架(scaffold)或骨幹,使細胞形成並 維持三維空間的結構。可於本發明組合使用選自以下群組之聚合 物:膠原蛋白、聚麵胺酸(polyglutamic acid,PGA)、聚乳酸交酉旨 -乙醇酸(poly lactide-glycolic acid,PLGA)、聚填酸#5 (calcium polyphosphate )、六 It 異丙醇絲(hexafluoroisopropanol silk,HFIP silk)、及前述之組合。較佳地,係於本發明組合使用膠原蛋白。 膠原蛋白亦稱為骨膠原,目前已知有二十九種不同的膠原蛋 白,分別存在於動物體内各組織中。膠原蛋白具有特殊的三股螺 旋纏繞結構,於三條相互獨立的膠原蛋白胜肽鏈之間藉由甘氨酸 形成的氫鍵維持纏繞結構,此三股螺旋結構賦予膠原蛋白優異的 機械強度與彈性。此外,膠原蛋白可經由交聯作用而形成更穩固 的結構。由於膠原蛋白具有優異之韌性與彈性,且具有高度生物 相容性,故常運用於組織工程中。因此,於本發明中,較佳係使 用膠原蛋白作為細胞支架;而在所有膠原蛋白中,第一型(type I) 膠原蛋白與第二型(type II)膠原蛋白係牙齒與軟骨組織中之主要 成分。因此,於本發明中,更佳係使用第一型或第二型膠原蛋白。 201204834 本發明之組合可呈—混合物之形式,或採各成分相互獨立之形 二原則上’只要組合中之生長激素與人工或天然聚合物不會不 相互影響’則可呈混合物之形式(如乾粉混合物)。舉例言之, ::中包含成骨蛋白與膠原蛋白時,由於二者並不會相互影 合物’即’將成骨蛋白與膠原蛋白混合在 二起。惟,ϋ於生錢素與人工或天然聚合物可能須要不同_201204834 VI. INSTRUCTIONS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a combination for regenerating teeth, and more particularly to a combination of a species with adipose stem cells and for regenerating teeth.曰[Prior Art] In dental treatment, when the teeth are missing due to factors such as rainbow teeth, age, orthodontic surgery (4), when they are removed, they will be treated with filling, implant or denture reconstruction. . Whether filling, implant or denture reconstruction, artificial materials are currently used to replace the original tooth components, such as titanium, £ or composite resin. However, the human body may be repulsive to artificial materials, and the material of the human body is easily damaged due to lack of wear and tear, and even the entire tooth is lost. Therefore, if the teeth can be naturally regenerated, the problems caused by the treatment or reconstruction of the teeth using artificial materials can be avoided. The technology of regenerative medicine involves the differentiation of stem cells into specific cell types and combined with tissue engineering to grow into new tissues or organs to replace damaged tissues or organs, thereby exerting normal physiological functions. In the case of dental regenerative medicine, dental pulp stem cells, periodontal ligament stem cells and bone marrow mesenchymal stem cells have been used as sources of stem cells, so that although dental pulp stem cells and periodontal ligament stem cells can be used as the most direct regeneration of teeth. The source of cells, because it is rare in the human body, it is difficult to obtain sufficient amount for treatment; while the bone marrow mesenchymal stem cells have the disadvantage of being scarce in availability, they are easy to age due to age, and must Obtained in the form of bone marrow extraction, so there are many limitations in practical applications. On the other hand, in addition to stem cell sources, how to use appropriate growth hormone and scaffold components, 3 201204834 to differentiate stem cells and further grow into well-structured and functional teeth, is also the key to dental regenerative medicine. . Therefore, in order for regenerative medicine to be practically applied to clinical dental treatment, a stable, abundant and readily available source of stem cells is required. The present invention is directed to the above needs, and the inventors of the present invention have found that the use of a combination of an adipose stem cell and a growth hormone and a biomedical material can successfully regenerate the teeth, and the regenerated tooth has a sound structure and function. SUMMARY OF THE INVENTION One object of the present invention is to provide a combination with adipose stem cells for regenerating teeth comprising a growth hormone and an artificial and/or natural polymer. Another object of the present invention is to provide a combination for regenerating teeth comprising adipose stem cells, a growth hormone, and an artificial and/or natural polymer. The detailed description of the present invention and the preferred embodiments thereof will be described in the following description of the present invention. [Embodiment] As mentioned above, the current filling, implant or denture reconstruction is the use of artificial materials as a substitute for natural tooth components, but it has the disadvantage of causing repulsion or repeated repair due to wear, and dental regenerative medicine can solve This problem. However, currently studied dental pulp stem cells, periodontal ligament stem cells or bone marrow mesenchymal stem cells are not a stable and abundant source of stem cells. Adipose-derived stem cells belong to adult stem cells and are characterized by their aging resistance. They can be obtained in large quantities by general liposuction, so they can be used as a source of stem cells that are stable and rich in 201204834. In addition, adipose stem cells have low immunological repellency, so that allogeneic transplantation of adipose stem cells between animals can be performed, and is not limited to autologous transplantation, and therefore, it has high flexibility of application. In view of the above, the present invention applies adipose stem cells to dental regenerative medicine, and provides a combination with adipose stem cells for regenerating teeth, and the combination comprises a growth hormone and an artificial and/or natural polymer. In the combination of the present invention, growth hormone selected from the group consisting of bone morphogenetic protein (BMP), dentin matrix protein (DMP), growth differentiation factor (Growth/differentiation factor, Gdf), and combinations of the foregoing. The growth hormone acts as a message molecule that causes the adipose stem cells to differentiate and form dental tissue. Osteogenic proteins, also known as bone morphogenetic proteins, are currently known to have twenty different osteogenic proteins, which are a transforming growth factor that induces differentiation of undifferentiated mesenchymal stem cells. Chondrogenic cells or osteoblasts promote proliferation, so osteogenic proteins are involved in the growth and repair and reconstruction of cartilage and osteogenesis. In addition to osteogenic protein, it promotes the formation of cartilage and osteogenesis, and also regulates the development and morphogenesis of embryonic cells in tissues or organs. A dentine matrix protein, or dentin matrix protein, is a non-colloidal protein involved in the calcification of bones and teeth, which is secreted by bone cells or dentate mother cells to promote extracellular or dentate formation. Growth differentiation factors are important biomessages for cell development, which promote chondrocyte proliferation and periodontal tissue formation. Preferably, the combination of the invention may comprise a growth hormone selected from the group consisting of osteogenic protein-2 (BMP-2), osteogenic protein-4 (BMP-4), osteogenic protein-7 (BMP-7). , osteogenic protein-11 (BMP-11), dentine matrix protein-1 (DMP-1), growth differentiation factor-11 (Gdf-11), and combinations thereof. Most preferably, the combination comprises osteogenic protein-2. 201204834 Osteogenic protein-2 is a disulfide homodimer protein with a molecular weight of about 30 kilodaltons (kDal), which can be obtained by automated purification in an object or by artificial gene selection. However, due to the low content of osteogenic protein-2 in animals, and the osteogenic protein-2 derived from different individuals has a very different activity in inducing stem cell differentiation, it is usually an osteogenic protein selected by artificial gene-- 2. In one embodiment of the present invention, recombinant human BMP-2 is used. In the combination of the present invention, a polymer is included as a scaffold or a backbone when the adipose stem cells differentiate and further form dental tissues, allowing the cells to form and maintain a three-dimensional structure. A polymer selected from the group consisting of collagen, polyglutamic acid (PGA), polylactic acid-glycolic acid (PLGA), and poly-acid can be used in combination with the present invention. #5 (calcium polyphosphate), hexafluoroisopropanol silk (HFIP silk), and combinations thereof. Preferably, collagen is used in combination in the present invention. Collagen is also known as collagen. Twenty-nine different collagen proteins are known to exist in tissues of animals. Collagen has a special three-strand-wound structure that maintains a entangled structure between the three independent collagen peptide chains by a hydrogen bond formed by glycine, which imparts excellent mechanical strength and elasticity to collagen. In addition, collagen can form a more stable structure via cross-linking. Because collagen has excellent toughness and elasticity and is highly biocompatible, it is often used in tissue engineering. Therefore, in the present invention, it is preferred to use collagen as a cell scaffold; and among all collagens, type I collagen and type II collagen are in the teeth and cartilage tissues. Main ingredients. Therefore, in the present invention, it is more preferred to use collagen of the first type or the second type. 201204834 The combination of the present invention may be in the form of a mixture, or in the form of a separate component of each component, in principle, as long as the growth hormone in the combination does not interact with the artificial or natural polymer, then it may be in the form of a mixture (eg, Dry powder mixture). For example, when :: osteogenic protein and collagen are included in the ::, the two do not interact with each other 'that is, the osteogenic protein and collagen are mixed together. However, it may be different from raw or natural polymers.

存環境(例如不同的ρΗ值、防腐劑或含水量等),故本發❸且八 亦可採各成分相互獨立之形式,以維持各成分之最佳活性或狀態口。 另一方面,視選用之生長激素與人工或天《合物㈣,本發 ==呈溶液、粉末、懸浮液或其他形式。由於生長激素主要 二蛋冑’故為防止生長激素變性(denature),一般須將其置於 3有鹽分的緩衝溶液中,或者,可以低溫冷綠燥的方式將生長 激素製成粉末,並置於4°c以下之低溫儲存。此外,若選用之聚 合物為蛋白f(例如_蛋白絲麵紐),财村依 而呈溶液或粉末之形式。 边方式 • 目此,本發明組合中之各成分可相互混合或分離,且可同時為 粉末、溶液、料液或其他形式,錢立地各別為粉末、溶液、 懸洋液或其他形式,或者’採—成分溶於另—齡之方式等 …、特別限制料’可於本發明組合巾添加防㈣或乾燥劑 延長其保存期限。 本發明所屬領域具通常知識者,基於本文之教導,可於本發明 ,-且。中’視選用之生長激素或聚合物的種類而調整其用量。較佳 地’本發明組合令之生長激素與聚合物之重量比例為約1: 1 _ 至約1 . 12〇,_’更佳為約1 : 6,000至約1 : 60,000,最佳為約卜 201204834 9,000 至約 1 : 12,000。 可將本發明組合連同脂肪幹細胞移植入一牙齒缺損或經拔除之 齒槽中’以進行牙齒再生。於此’可視需要調整脂肪幹細胞之用 量,舉例言之,當將該組合用於部分牙齒之修補或再生時,脂肪 幹細胞之用量可較低;而將該組合用於全牙再生時,則可增加脂 肪2幹細胞之用量。麟幹城之用量—般為每奈克生長激素約& 1〇2至約5Χ106個’較佳為約5χ1〇3至約5χ1〇5個更佳為約5χΐ〇4 至約1x10個。此外,如上述,脂肪幹細胞之免疫排斥性低故可 進行同種動物間之脂肪幹細胞的異體移植,因此,於本發明中, 除可使用來自待移植之動物體的脂肪幹細胞之外,’亦可使用來自 同種之其他動物體的脂肪幹細胞。 本發明亦提供另-種用於再生牙齒之組合,其包含脂肪幹細 胞、-生長激素及-人卫及/或天然之聚合物。其中,該生長激素 及人工及/或天然之聚合物的觀、用量與形式,以及脂肪幹細胞 之來源與含量’皆如上文中所定義者。此外,#於脂肪幹細胞之 高敏感性’其賴存於嚴苛條件之環境巾,始能料生命力並防 止污染’且為避免生長激素或聚合物影響脂肪幹細胞,因此,於 此組合中,麟幹細胞—般係採單獨存在之m於移植前始 與生長激素及聚合物混合。 由於牙齒再生之關鍵為脂肪幹細胞須成功地分化’並進而形成 牙齒組織,故維持脂肪幹細胞之生命力,以及保持生長激素與 合物之活性或新鮮度,以於最佳條件下使牙齒再生為首要考量 者。為此’可於即將進行移植手術之前,始依適當比例混合脂肪 幹細胞、生長激素、及人工及/或天然聚合物以提供本發明再生牙 201204834 齒之組合,以於組合中各成分為高活性且新鮮之狀態下,進行牙 齒再生。 於本發明之一實施態樣中,係於移植手術即將進行前,始配製 一包含脂肪幹細胞、成骨蛋白-2、及膠原蛋白的組合,且成骨蛋 白-2與膠原蛋白之重量比例為約1 : 11,250,且脂肪幹細胞之用量 為每奈克生長激素約5x 104個,並將其移植入動物的齒槽内,以進 行牙齒再生。 鑒於本發明組合可使牙齒再生,故其可運用於牙齒之修補、替 換、及/或重建。 茲以下列具體實施態樣以進一步例示說明本發明。其中該些實 施態樣僅提供作為說明,而非用以限制本發明之範疇。 [製備例】製備用於再生牙齒之組合 參考第1圖,依以下步驟及比例製備本發明之用於再生牙齒之 組合,並進行移植。 A、配置1.35毫升之溶液A (置於冰上),包含: 5.7><DMEM (Dulbecco’s modified Eagle’s 培養基) 0.5 毫升 4-(2-羥乙基)-1-哌嗪乙磺酸(HEPES,0.1莫耳濃度)0.5毫升 0.25毫升 50微升 50微升 2.15毫升 1.5毫升The environment (e.g., different pH values, preservatives, water content, etc.) may be used in the form of separate components to maintain the optimum activity or condition of each component. On the other hand, depending on the growth hormone selected and the artificial or natural compound (4), the present invention is in the form of a solution, a powder, a suspension or the like. Since the growth hormone is mainly two egg tarts, in order to prevent growth hormone denaturation, it is generally required to be placed in a buffer solution of 3 salts, or the growth hormone can be powdered and placed in a low-temperature cold green manner. Store at a low temperature below 4°C. In addition, if the selected polymer is protein f (e.g., _ protein silk noodle), the village is in the form of a solution or a powder. Side Modes • The components of the combinations of the present invention may be mixed or separated from each other, and may be in the form of a powder, a solution, a liquid, or the like, respectively, in the form of a powder, a solution, a suspension, or the like, or 'Collection - the ingredients are dissolved in another age, etc., and the special limit material' can be added to the combination towel of the present invention to prevent the (four) or desiccant from extending the shelf life. The present invention is generally known to those skilled in the art, based on the teachings herein, and may be used in the present invention. The amount is adjusted depending on the type of growth hormone or polymer selected. Preferably, the combination of the present invention has a weight ratio of growth hormone to polymer of from about 1:1 _ to about 1.12 〇, _' more preferably from about 1:6,000 to about 1:60,000, most preferably about 201204834 9,000 to approximately 1: 12,000. The combination of the invention, together with adipose stem cells, can be transplanted into a tooth defect or extracted from the alveolus for tooth regeneration. Here, the amount of the adipose stem cells can be adjusted as needed. For example, when the combination is used for repair or regeneration of a part of the teeth, the amount of the adipose stem cells can be low; and when the combination is used for the whole tooth regeneration, Increase the amount of fat 2 stem cells. The amount of Lingancheng is generally from about 1 to 2 to about 5,106' per gram of growth hormone, preferably from about 5χ1〇3 to about 5χ1〇5, more preferably from about 5χΐ〇4 to about 1x10. Further, as described above, since the adipose stem cells have low immunological repellency, allogeneic transplantation of adipose stem cells between animals can be performed. Therefore, in the present invention, in addition to the adipose stem cells from the animal to be transplanted, Use adipose stem cells from other animal species of the same species. The present invention also provides another combination for regenerating teeth comprising a fat stem cell, a growth hormone, and a human and/or natural polymer. Wherein, the form, amount and form of the growth hormone and the artificial and/or natural polymer, and the source and content of the adipose stem cells are as defined above. In addition, #high sensitivity of adipose-derived stem cells, which are based on harsh environmental conditions, can be used to prevent vitality and prevent contamination, and in order to avoid growth hormone or polymer affecting adipose stem cells, therefore, in this combination, Lin Stem cells are usually mixed with growth hormone and polymer before transplantation. Since the key to tooth regeneration is that adipose stem cells must successfully differentiate and form tooth tissue, the vitality of the adipose stem cells is maintained, and the activity or freshness of the growth hormone and the compound are maintained to regenerate the teeth under optimal conditions. Consider the person. To this end, adipose stem cells, growth hormone, and artificial and/or natural polymers can be mixed in an appropriate ratio to provide a combination of the regenerated tooth of the present invention 201204834 before the transplantation operation is performed, so that the components in the combination are highly active. In the fresh state, the teeth are regenerated. In one embodiment of the present invention, a combination comprising adipose stem cells, osteogenic protein-2, and collagen is prepared before the transplantation operation is performed, and the weight ratio of osteogenic protein-2 to collagen is Approximately 1:11,250, and the amount of adipose stem cells is about 5 x 104 per gram of growth hormone, and transplanted into the alveolar of the animal for tooth regeneration. Since the combination of the present invention allows for the regeneration of teeth, it can be used for the repair, replacement, and/or reconstruction of teeth. The invention is further illustrated by the following specific embodiments. The embodiments are provided by way of illustration only and are not intended to limit the scope of the invention. [Preparation Example] Preparation of a combination for regenerating teeth Referring to Fig. 1, a combination for regenerating teeth of the present invention was prepared in the following steps and ratios, and transplanted. A. Configure 1.35 ml of solution A (on ice) containing: 5.7><DMEM (Dulbecco's modified Eagle's medium) 0.5 ml of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) , 0.1 molar concentration) 0.5 ml 0.25 ml 50 μl 50 μl 2.15 ml 1.5 ml

NaHC03 (2.5 重量%)NaHC03 (2.5 wt%)

CaCl2 (0.17莫耳濃度)CaCl2 (0.17 molar concentration)

NaOH ( 1當量濃度) B、配置3.65毫升之溶液B,包含: DMEM (含23.3重量%胎牛血清) 第一型膠原蛋白(3.75毫克/毫升) 201204834 C、 培養兔子脂肪幹細胞(rabbit adipose tissue-derived stem cell ’ rADSCs )或作為正對照組之兔子牙髓幹細胞(rabbit dental pulp stem cells,rDPSCs),如第2圖所示,其會呈現典型的間 質幹細胞的細胞形態。將培養之兔子脂肪幹細胞或兔子牙髓幹 細胞以胰蛋白酶作用3分鐘後,再將細胞懸浮液以1000轉/ 分鐘之轉速離心5分鐘,丟棄上清液,收集定量5χ106個細胞 並置於36.5微升之溶液Β中,以製成一細胞懸浮液。 D、 於步驟C製得之細胞懸浮液中加入1〇〇奈克/毫升之成骨蛋白 -2 ( R&D Systems Catalog Number 355-BEC)。 E、 在冰上將13.5微升之溶液A及溶液Β (包含成骨蛋白-2與脂 肪幹細胞或牙髓幹細胞)混合均勻後,立即加入至一48孔細 胞培養盤中。 F、 將該細胞培養盤置於一 37°C、含有5體積%之C02的細胞培 養箱中作用2小時,待膠原蛋白聚合凝固成凝膠後,即可進行 移植。NaOH (1 equivalent concentration) B, configuration 3.65 ml of solution B, containing: DMEM (containing 23.3% by weight fetal bovine serum) Type I collagen (3.75 mg / ml) 201204834 C, cultured rabbit adipose tissue (rabbit adipose tissue- The derived stem cell 'rADSCs' or rabbit dental pulp stem cells (rDPSCs), as shown in Fig. 2, showed typical cell morphology of mesenchymal stem cells. After cultured rabbit adipose stem cells or rabbit dental pulp stem cells were trypsinized for 3 minutes, the cell suspension was centrifuged at 1000 rpm for 5 minutes, the supernatant was discarded, and 5 χ 106 cells were collected and placed at 36.5 μl. The solution is mashed to make a cell suspension. D. Add 1 μg/ml of osteogenic protein-2 (R&D Systems Catalog Number 355-BEC) to the cell suspension prepared in step C. E. Mix 13.5 μl of solution A and solution Β (containing osteogenic protein-2 with adipose stem cells or dental pulp stem cells) on ice, and immediately add to a 48-well cell culture dish. F. The cell culture plate was placed in a cell culture chamber containing 5% by volume of CO 2 at 37 ° C for 2 hours, and after the collagen was polymerized and solidified into a gel, the transplantation was carried out.

[實施例I A.移植用於再生牙齒之組合 首先’將紐西蘭大白兔(購自台灣,林國鈞養兔廠,彰化縣北 斗鎮四維路115號)麻醉後,分別拔除其一顆上門牙及一顆下門 牙’並等待接受移植。將實施例1中製得之組合凝膠(包含成骨 蛋白-2與脂肪幹細胞或牙髓幹細胞)直接移植並置入於兔子經拔 除下門牙的齒槽中,並以縫線縫合牙齦。另外,於經拔除上門牙 的齒槽中植入含有成骨蛋白-2、但不含任何幹細胞的膠原蛋白凝 201204834 膠,以作為對照組,並同樣以縫線縫合牙齦,即完成移植步驟。 Β· X光攝影及解剖分析 於完成移植手術15週後,以X光攝影觀察兔子經拔除上門牙及 下門牙的齒槽,結果係如第3A圖所示,可以觀察到下門牙齒槽内 之經移植處有牙齒新生,然而,於作為對照組之上門牙齒槽内並 無牙齒新生(第3A圖,箭頭處)。另外,以解剖方式進行觀察, 結果係如第3B圖所示,顯示經過包含脂肪幹細胞或牙髓幹細胞之 組合移植的齒槽内皆有牙齒新生,但於對照組之齒槽中則無牙齒 新生(第3B圖,白色箭頭處)。此試驗結果說明,本發明之組合 可成功使牙齒再生。 C. H&E組織染色分析 以H&E染色試劑(包含蘇木素(Mayer’s Hemalum Solution, 購自 MerckTM )及伊紅(Eosin Y Solution Alcoholic,購自 Sigma-AldrichTM ))染色兔子的再生牙齒組織與正常牙齒組織,並 進行分析比對,結果顯示於第4A圖至第4C圖。 如第4A圖所示,經過包含牙髓幹細胞或脂肪幹細胞之組合移植 的齒槽中皆能再生長出類似於正常牙齒的組織結構。此外,如第 4B圖所示,再生新牙的細部結構與正常牙齒相同,都具有齒質 (D : Dentin )、齒堊質(C : Cementum )、牙周動帶(PDL : Periodontal ligament),且於高倍率(ΙΟΟΟχ)顯微鏡之觀察下,可看見由牙周 韋刀帶延伸進入齒堊質的Sharpey氏纖維(第4B圖,白色箭頭處)。 另外,如第4C圖所示,再生的牙齒組織皆具有牙髓的結構,代表 再生牙齒具有自我更新的能力。 201204834 D·綠色免疫螢光染色分析 以綠色免疫螢光染色試劑(包含溫韋伯氏因子(v〇n湖咖⑽ factor )或Beta 3-微管素(tubulin ),abcamTM )染色兔子的再生牙 齒組織與正常牙齒_,並進行分析比對,結果顯示於第5A圖及 第5B圖。 如第5A圖所示’經過包含牙髓幹細胞或脂肪幹細胞之組合移植 所新生長出來的牙髓(pulp)及牙周韌帶(pDL)中,皆有新生血 管形成。料,如帛5B圖所示,兔子再生的牙髓及牙周物帶中皆 有神經纖維支配(第5B圖’白色箭頭處)。 上述B至C之分析結果顯示,本發明組合可成功地使牙齒再 生,且再生之新牙具有與正常牙齒相同之完整結構,故可進行正 常之咀嚼功能。 上述實施例僅係用以例示說明本發明之原理及功效,而非用於 限制本發明。任何熟於此項技藝之人士均可在不違背本發明之技 術原理及精神的情況下,對上述實施例進行修改及變化。因此, 本發明之權利保護範圍應如後述之申請專利範圍所列者。 【圖式簡單說明】。 第1圖係本發明之用於再生牙齒之組合之製備及移植的流程圖; 第2圖係兔子牙髓幹細胞與兔子脂肪幹細胞的光學顯微鏡圖; 第3A圖係兔子上門牙及下門牙之齒槽的χ光攝影圖; 第3Β圖係兔子上門牙及下門牙之齒槽的解剖圖; 第4Α圖至第4C圖係兔子新生牙齒組織與正常牙齒組織的η&ε 12 201204834 組織染色圖;以及 第5A圖及第5B圖係兔子新生牙齒組織與正常牙齒組織的綠色免 疫螢光組織染色圖。 【主要元件符號說明】 (無)。[Example I A. Transplantation for regenerative teeth first] The New Zealand White Rabbit (purchased from Taiwan, Lin Guoyu Rabbit Factory, No. 115, Siwei Road, Beidou Town, Changhua County) was anesthetized and then removed one of the upper front teeth. And a lower incisor' and waiting to be transplanted. The combination gel prepared in Example 1 (including osteogenic protein-2 and adipose stem cells or dental pulp stem cells) was directly transplanted and placed in a sulcus in which the rabbit was removed, and the gingiva was sutured with a suture. In addition, a collagen gelatin 201204834 gel containing osteogenic protein-2 but no stem cells was implanted into the alveolar detachment of the upper incisor to serve as a control group, and the gingiva was also sutured by suture, that is, the transplantation step was completed. Β·X-ray photography and anatomical analysis After 15 weeks of completion of the transplant operation, the rabbits were removed by X-ray photography to remove the canines of the upper and lower incisors. As a result, as shown in Figure 3A, the lower door can be observed. There was tooth regeneration at the transplant site, however, there was no tooth regeneration in the tooth groove of the upper door as a control group (Fig. 3A, arrow). In addition, observations were performed anatomically, and the results were as shown in Fig. 3B, showing that teeth were newly regenerated in the alveolar cells containing a combination of adipose stem cells or dental pulp stem cells, but no tooth regeneration occurred in the alveolar cells of the control group. (Fig. 3B, white arrow). The results of this test demonstrate that the combination of the present invention can successfully regenerate teeth. C. H&E tissue staining analysis Regenerated tooth tissue and normal staining of rabbits stained with H&E staining reagent (including Mayer's Hemalum Solution (available from MerckTM) and Eosin Y Solution Alcoholic (purchased from Sigma-AldrichTM)) The tooth tissues were analyzed and compared, and the results are shown in Figures 4A to 4C. As shown in Fig. 4A, the tissue structure similar to normal teeth can be regenerated in the alveolus transplanted by a combination of dental pulp stem cells or adipose stem cells. In addition, as shown in Fig. 4B, the detailed structure of the regenerated tooth has the same tooth shape (D: Dentin), gingival mass (C: Cementum), and periodontal ligament (PDL). And under the observation of a high-magnification (ΙΟΟΟχ) microscope, Sharpey's fiber extending from the periodontal strip to the gingival mass (Fig. 4B, white arrow) can be seen. In addition, as shown in Fig. 4C, the regenerated tooth tissue has a structure of the pulp, which represents the ability of the regenerated tooth to self-renew. 201204834 D·Green immunofluorescence staining analysis of regenerative tooth tissue of rabbits stained with green immunofluorescence staining reagent (including Wyperber's factor (v〇n lake coffee (10) factor) or Beta 3-tubulin (abulin) The results were compared with the normal teeth _, and the results are shown in Fig. 5A and Fig. 5B. As shown in Fig. 5A, new blood vessels are formed in the newly grown pulp and periodontal ligament (pDL) which are transplanted by a combination of dental pulp stem cells or adipose stem cells. The material, as shown in Fig. 5B, is dominated by nerve fibers in the pulp and periodontal strips regenerated by the rabbit (Fig. 5B 'white arrow'). The analysis results of the above B to C show that the combination of the present invention can successfully regenerate the teeth, and the regenerated new teeth have the same intact structure as the normal teeth, so that the normal chewing function can be performed. The above-described embodiments are merely illustrative of the principles and effects of the invention and are not intended to limit the invention. Modifications and variations of the above-described embodiments can be made by those skilled in the art without departing from the spirit and scope of the invention. Therefore, the scope of protection of the present invention should be as set forth in the appended claims. [Simple description of the diagram]. 1 is a flow chart of preparation and transplantation of a combination for regenerating teeth of the present invention; FIG. 2 is an optical micrograph of rabbit dental pulp stem cells and rabbit adipose stem cells; FIG. 3A is a tooth of a rabbit upper incisor and a lower incisor The χ 摄影 摄影 第 第 ; ; ; ; 第 第 第 第 第 第 第 第 第 ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; And Figures 5A and 5B show green immunofluorescence staining of rabbit new tooth tissue and normal tooth tissue. [Main component symbol description] (none).

Claims (1)

201204834 七、申請專利範圍: 1. 一種與脂肪幹細胞併用以再生牙齒之組合,包含一生長激素及 一人工及/或天然之聚合物。 2. 如請求項1之組合,其中該生長激素係選自以下群組:成骨蛋 白(bone morphogenetic protein,BMP )、齒質基質蛋白(dentin matrix protein,DMP)、生長分化因子(Growth/differentiation factor ’ Gdf)、及前述之組合。 3 ·如請求項2之組合,其中該生長激素係選自以下群組:成骨蛋 白-2、成骨蛋白-4、成骨蛋白-7、成骨蛋白-11、齒質基質蛋白 _ -1、生長分化因子-11、及前述之組合。 4. 如請求項3之組合,其中該生長激素係成骨蛋白-2。 5. 如請求項1之組合,其中該聚合物係選自以下群組:膠原蛋 白、聚楚胺酸(polyglutamic acid,PGA)、聚乳酸交S旨-乙醇 酸(poly lactide-glycolic acid,PLGA)、聚填酸釣(calcium polyphosphate)、六氟異丙醇絲(hexafluoroisopropanol silk ’ ΗΠΡ silk)、及前述之組合。 6. 如請求項5之組合,其中該聚合物係膠原蛋白。 ® 7. 如請求項1至6中任一項之組合,其中該生長激素與該聚合物 之重量比例為約1 : 1,200至約1 : 120,000。 8. 如請求項7之組合,其中該生長激素與該聚合物之重量比例為 約 1 : 6,〇〇〇 至約 1 : 60,000。 9. 如請求項8之組合,其中該生長激素與該聚合物之重量比例為 約 1 : 9,〇〇〇 至約 1 : 12,000。 10. —種用於再生牙齒之組合,包含脂肪幹細胞、一生長激素及一 14 201204834 人工及/或天然之聚合物。 11·如清求項10之組合,其中該生長激素係選自以下群組:成骨 蛋白、齒質基質蛋白、生長分化因子、及前述之組合。 12.如4求項u之組合’其中該生長激素係選自以下群組:成骨 蛋白-2、成骨蛋白-4、成骨蛋白_7、成骨蛋白_u、齒質基質蛋 白_1、生長分化因子_U、及前述之組合。 13’如μ求項12之組合’其中該生長激素係成骨蛋白。 月求項10之組合,其中該聚合物係選自以下群組:膠原蛋 白聚麵胺酸、聚乳酸交酯-乙醇酸、聚磷酸鈣、六氟異丙醇 絲、及前述之組合。 15.如明求項14之組合,其中該聚合物係膠原蛋白。 Μ.如明求項1〇至15中任一項之組合其中該生長激素與該聚合 物之重里比例為約丨:12〇〇至約i : ⑼,且脂肪幹細胞 之含量為每奈克生長激素約5χ1〇2至約5乂1〇6個。 17.如凊求項16之組合,其中該生長激素與該聚合物之重量比例 為約1 . 6,000至約υ 6〇〇〇〇 ,且脂肪幹細胞之含量為每奈克 生長激素約5xl〇3至約5χ1〇5個。 18·如凊求項17之組合’其中該生長激素與該聚合物之重量比例 為約1 : 9,000至約丨:12,〇〇〇,且脂肪幹細胞之含量為每奈克 生長激素約5xl〇4至約以丨…個。 15201204834 VII. Patent Application Range: 1. A combination with adipose stem cells and used to regenerate teeth, comprising a growth hormone and an artificial and/or natural polymer. 2. The combination of claim 1, wherein the growth hormone is selected from the group consisting of bone morphogenetic protein (BMP), dentin matrix protein (DMP), growth differentiation factor (Growth/differentiation). Factor ' Gdf), and combinations of the foregoing. 3. The combination of claim 2, wherein the growth hormone is selected from the group consisting of osteogenic protein-2, osteogenic protein-4, osteogenic protein-7, osteogenic protein-11, dentine matrix protein _- 1. Growth Differentiation Factor-11, and combinations thereof. 4. The combination of claim 3, wherein the growth hormone is osteogenic protein-2. 5. The combination of claim 1, wherein the polymer is selected from the group consisting of collagen, polyglutamic acid (PGA), polylactic acid-glycolic acid (PLGA). ), calcium polyphosphate, hexafluoroisopropanol silk 'ΗΠΡ silk, and combinations of the foregoing. 6. The combination of claim 5, wherein the polymer is collagen. The combination of any one of claims 1 to 6, wherein the weight ratio of the growth hormone to the polymer is from about 1:1,200 to about 1:120,000. 8. The combination of claim 7, wherein the weight ratio of the growth hormone to the polymer is from about 1:6 to about 1:60,000. 9. The combination of claim 8, wherein the weight ratio of the growth hormone to the polymer is from about 1:9 to about 1:12,000. 10. A combination for regenerating teeth comprising adipose stem cells, a growth hormone, and a polymer of 201204834 artificial and/or natural. 11. The combination of claim 10, wherein the growth hormone is selected from the group consisting of osteogenic proteins, dentine matrix proteins, growth differentiation factors, and combinations thereof. 12. A combination of 4, wherein the growth hormone is selected from the group consisting of osteogenic protein-2, osteogenic protein-4, osteogenic protein-7, osteogenic protein _u, dentine matrix protein _ 1. Growth differentiation factor _U, and combinations thereof. 13' is a combination of μ and 12 wherein the growth hormone is osteogenic. The combination of claim 10, wherein the polymer is selected from the group consisting of collagen protein polyglycolic acid, polylactide-glycolic acid, calcium polyphosphate, hexafluoroisopropanol filament, and combinations thereof. 15. The combination of claim 14, wherein the polymer is collagen. The combination of any one of the items 1 to 15 wherein the weight ratio of the growth hormone to the polymer is about 丨: 12 〇〇 to about i: (9), and the content of the adipose stem cells is per gram of growth. The hormone is about 5χ1〇2 to about 5乂1〇6. 17. The combination of claim 16, wherein the weight ratio of the growth hormone to the polymer is from about 6,000 to about 〇〇〇〇6 〇〇〇〇, and the content of the adipose stem cells is about 5 x 10 每 3 per gram of growth hormone. It is about 5χ1〇5. 18. The combination of claim 17 wherein the weight ratio of the growth hormone to the polymer is from about 1: 9,000 to about 丨:12, 〇〇〇, and the content of the adipose stem cells is about 5 x 1 per gram of growth hormone. 4 to about 丨... 15
TW99123850A 2010-07-20 2010-07-20 Combination for tooth regeneration TW201204834A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99123850A TW201204834A (en) 2010-07-20 2010-07-20 Combination for tooth regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99123850A TW201204834A (en) 2010-07-20 2010-07-20 Combination for tooth regeneration

Publications (1)

Publication Number Publication Date
TW201204834A true TW201204834A (en) 2012-02-01

Family

ID=46761383

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99123850A TW201204834A (en) 2010-07-20 2010-07-20 Combination for tooth regeneration

Country Status (1)

Country Link
TW (1) TW201204834A (en)

Similar Documents

Publication Publication Date Title
Tahmasebi et al. Current biocompatible materials in oral regeneration: a comprehensive overview of composite materials
Sun et al. Biological approaches toward dental pulp regeneration by tissue engineering
Prescott et al. In vivo generation of dental pulp-like tissue by using dental pulp stem cells, a collagen scaffold, and dentin matrix protein 1 after subcutaneous transplantation in mice
US8979534B2 (en) Tooth scaffolds
JP4982841B2 (en) Regenerative medical bone composition
Kosen et al. Application of collagen hydrogel/sponge scaffold facilitates periodontal wound healing in class II furcation defects in beagle dogs
US20090148486A1 (en) Compositions and methods for treating pulp inflammations caused by infection or trauma
Mahajan Periosteum: a highly underrated tool in dentistry
US20090274627A1 (en) Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same
Yang et al. Periodontal regeneration with nano-hyroxyapatite-coated silk scaffolds in dogs
Ding et al. Bone regeneration of canine peri-implant defects using cell sheets of adipose-derived mesenchymal stem cells and platelet-rich fibrin membranes
Yazdanian et al. Decellularized and biological scaffolds in dental and craniofacial tissue engineering: A comprehensive overview
Galler et al. Biomaterials and their potential applications for dental tissue engineering
Alshehadat et al. Scaffolds for dental pulp tissue regeneration: A review
US8822212B2 (en) Methods for forming tooth root and periodontal tissue unit, and regenerated tooth
Boeckel et al. Cell culture–based tissue engineering as an alternative to bone grafts in implant dentistry: a literature review
US20150335400A1 (en) Tooth scaffolds
Grawish et al. Challenges of engineering biomimetic dental and paradental tissues
AU2009283516B2 (en) Method for restoring missing tooth and method for producing restorative material
Manju et al. Evaluation of osseointegration of staged or simultaneously placed dental implants with nanocomposite fibrous scaffolds in rabbit mandibular defect
Kocak Oztug et al. Regenerative approaches in periodontics
Chen et al. Anchoring dental implant in tissue-engineered bone using composite scaffold: a preliminary study in nude mouse model
Ni et al. Stem‐cell based soft tissue substitutes: Engineering of crosslinked polylysine‐hyaluronic acid microspheres ladened with gingival mesenchymal stem cells for collagen tissue regeneration and angiogenesis
Smith et al. Craniofacial regenerative medicine
CN102335457A (en) Composition for tooth regeneration